Cargando…
Antiviral therapy reduces rebleeding rate in patients with hepatitis B-related cirrhosis with acute variceal bleeding after endotherapy
BACKGROUND: The preventive effects of antiviral therapy to reduce rebleeding rate in patients with hepatitis B-related cirrhosis undergoing endoscopic treatment have not yet been reported. METHODS: In this retrospective cohort study, 1139 patients with chronic hepatitis B with first acute variceal b...
Autores principales: | He, Lingling, Ye, Xiaohui, Ma, Jiali, Li, Ping, Jiang, Yu, Hu, Julong, Yang, Junru, Zhou, Yuling, Liang, Xiuxia, Lin, Yijun, Wei, Hongshan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6588843/ https://www.ncbi.nlm.nih.gov/pubmed/31226942 http://dx.doi.org/10.1186/s12876-019-1020-2 |
Ejemplares similares
-
Clinical algorithms for the prevention of variceal bleeding and rebleeding in patients with liver cirrhosis
por: Pfisterer, Nikolaus, et al.
Publicado: (2021) -
Hepatic venous pressure gradient and rebleeding risk of patients with nonalcoholic steatohepatitis cirrhosis after variceal bleeding
por: Shi, Yiqi, et al.
Publicado: (2023) -
Associations Between Endoscopic Primary Prophylaxis and Rebleeding in Liver Cirrhosis Patients with Esophagogastric Variceal Bleeding
por: Gao, Yanying, et al.
Publicado: (2022) -
Mortality and rebleeding following variceal haemorrhage in liver cirrhosis and periportal fibrosis
por: Mohammed, Sara Elfadil Abbas, et al.
Publicado: (2016) -
A Practical Model for Predicting Esophageal Variceal Rebleeding in Patients with Hepatitis B-Associated Cirrhosis
por: Liu, Linxiang, et al.
Publicado: (2023)